TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹765 Cr | ₹501 Cr | ₹445 Cr | ₹393 Cr | ₹369 Cr |
What is the latest Long Term Provisions ratio of TORRENT PHARMACEUTICALS ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹765 Cr |
| Mar2025 | ₹501 Cr |
| Mar2024 | ₹445 Cr |
| Mar2023 | ₹393 Cr |
| Mar2022 | ₹369 Cr |
How is Long Term Provisions of TORRENT PHARMACEUTICALS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹765 Cr | 52.52 | |
| Mar2025 | ₹501 Cr | 12.72 | |
| Mar2024 | ₹445 Cr | 13.14 | |
| Mar2023 | ₹393 Cr | 6.60 | |
| Mar2022 | ₹369 Cr | - | |
Compare Long Term Provisions of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹186,369.4 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| MANKIND PHARMA | ₹108,129.0 Cr | 2.9% | 5.4% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -2.7% |
5.1% |
42.4% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses